A detailed history of Halpern Financial, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Halpern Financial, Inc. holds 1,570 shares of JNJ stock, worth $251,341. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,570
Previous 1,559 0.71%
Holding current value
$251,341
Previous $228 Million 11.05%
% of portfolio
0.07%
Previous 0.06%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$145.48 - $167.38 $1,600 - $1,841
11 Added 0.71%
1,570 $253 Million
Q1 2024

Apr 09, 2024

SELL
$155.22 - $162.74 $19,712 - $20,667
-127 Reduced 7.53%
1,559 $240 Million
Q4 2023

Jan 19, 2024

SELL
$145.6 - $158.88 $10,628 - $11,598
-73 Reduced 4.15%
1,686 $271 Million
Q1 2023

Sep 21, 2023

SELL
$151.05 - $180.26 $5,286 - $6,309
-35 Reduced 1.95%
1,759 $273 Million
Q4 2022

Sep 21, 2023

SELL
$160.2 - $179.79 $7,048 - $7,910
-44 Reduced 2.39%
1,794 $317 Million
Q3 2022

Sep 21, 2023

BUY
$161.33 - $179.52 $5,162 - $5,744
32 Added 1.77%
1,838 $300 Million
Q2 2022

Sep 21, 2023

BUY
$168.19 - $186.01 $11,436 - $12,648
68 Added 3.91%
1,806 $321 Million
Q1 2022

Sep 21, 2023

SELL
$158.14 - $179.59 $47,441 - $53,877
-300 Reduced 14.72%
1,738 $308 Million
Q4 2021

Sep 21, 2023

BUY
$155.93 - $173.01 $72,195 - $80,103
463 Added 29.4%
2,038 $349 Million
Q3 2021

Sep 21, 2023

BUY
$161.5 - $179.47 $192,508 - $213,928
1,192 Added 311.23%
1,575 $254 Million
Q1 2021

Sep 21, 2023

BUY
$153.07 - $170.48 $13,623 - $15,172
89 Added 30.27%
383 $62.9 Million
Q3 2020

Sep 21, 2023

SELL
$140.38 - $153.83 $140 - $153
-1 Reduced 0.34%
294 $43.8 Million
Q1 2020

Sep 21, 2023

SELL
$111.14 - $153.99 $15,781 - $21,866
-142 Reduced 32.49%
295 $38.7 Million
Q4 2019

Sep 21, 2023

BUY
$127.5 - $146.44 $55,717 - $63,994
437 New
437 $63.8 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $419B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Halpern Financial, Inc. Portfolio

Follow Halpern Financial, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Halpern Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Halpern Financial, Inc. with notifications on news.